CN108743780A - 一种含有植物提取物的外阴用护理液及其制备方法 - Google Patents
一种含有植物提取物的外阴用护理液及其制备方法 Download PDFInfo
- Publication number
- CN108743780A CN108743780A CN201810967951.4A CN201810967951A CN108743780A CN 108743780 A CN108743780 A CN 108743780A CN 201810967951 A CN201810967951 A CN 201810967951A CN 108743780 A CN108743780 A CN 108743780A
- Authority
- CN
- China
- Prior art keywords
- vulva
- plant extracts
- conditioning liquid
- containing plant
- liquid containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000419 plant extract Substances 0.000 title claims abstract description 34
- 239000007788 liquid Substances 0.000 title claims abstract description 33
- 210000003905 vulva Anatomy 0.000 title claims abstract description 33
- 230000003750 conditioning effect Effects 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000008213 purified water Substances 0.000 claims abstract description 13
- 230000002421 anti-septic effect Effects 0.000 claims abstract description 9
- 150000004676 glycans Chemical class 0.000 claims abstract description 9
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 9
- 239000005017 polysaccharide Substances 0.000 claims abstract description 9
- 239000004909 Moisturizer Substances 0.000 claims abstract description 7
- 230000001333 moisturizer Effects 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000002562 thickening agent Substances 0.000 claims abstract description 7
- 239000003755 preservative agent Substances 0.000 claims abstract description 6
- 230000002335 preservative effect Effects 0.000 claims abstract description 6
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 101710199886 Protein 0.5 Proteins 0.000 claims abstract description 3
- 239000000284 extract Substances 0.000 claims description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 102000008186 Collagen Human genes 0.000 claims description 8
- 108010035532 Collagen Proteins 0.000 claims description 8
- 229920001436 collagen Polymers 0.000 claims description 8
- -1 hydroxypropyl cyclodextrin Chemical compound 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 240000001432 Calendula officinalis Species 0.000 claims description 5
- 235000005881 Calendula officinalis Nutrition 0.000 claims description 5
- 229920000858 Cyclodextrin Polymers 0.000 claims description 5
- 239000001856 Ethyl cellulose Substances 0.000 claims description 5
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 5
- 241000208690 Hamamelis Species 0.000 claims description 5
- 241000405414 Rehmannia Species 0.000 claims description 5
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 230000003078 antioxidant effect Effects 0.000 claims description 5
- 235000006708 antioxidants Nutrition 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 5
- 229920001249 ethyl cellulose Polymers 0.000 claims description 5
- 241001116389 Aloe Species 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 235000011399 aloe vera Nutrition 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 claims description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 3
- 229920002413 Polyhexanide Polymers 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 229960002152 chlorhexidine acetate Drugs 0.000 claims description 3
- 238000005260 corrosion Methods 0.000 claims description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 3
- 230000003020 moisturizing effect Effects 0.000 claims description 3
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims description 3
- 229960005323 phenoxyethanol Drugs 0.000 claims description 3
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 239000000413 hydrolysate Substances 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 210000001215 vagina Anatomy 0.000 abstract description 9
- 241000894006 Bacteria Species 0.000 abstract description 4
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 4
- 230000032677 cell aging Effects 0.000 abstract description 2
- 238000004140 cleaning Methods 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 230000004936 stimulating effect Effects 0.000 abstract description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 18
- 210000001519 tissue Anatomy 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 5
- 230000008021 deposition Effects 0.000 description 5
- 229940011871 estrogen Drugs 0.000 description 5
- 239000000262 estrogen Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 4
- 230000001815 facial effect Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001313288 Labia Species 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920000433 Lyocell Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000013200 Stress disease Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- AFHJQYHRLPMKHU-WEZNYRQKSA-N aloin B Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-WEZNYRQKSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000011176 biofiber Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical group O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000000736 corneocyte Anatomy 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种含有植物提取物的外阴用护理液及其制备方法,由以下重量百分比的原料制成:多糖0.5%‑10%、蛋白质0.5%‑3%、植物提取物10%‑20%、抗氧化剂1%‑5%、保湿剂5%‑15%、增稠剂0.02%‑0.4%、抗菌剂0.01%‑0.1%、防腐剂0.05%‑0.5%,余量为纯化水。本发明具有滋养、活化阴道组织细胞,使外阴粉嫩的作用,并且恢复和保持阴道组织的自然弹性,延缓女性阴道细胞衰老,而且性质温和安全无刺激,健康环保,无需清洗,携带方便,制作工艺简单,同时具有很好的消炎、抑菌功能。
Description
技术领域
本发明涉及女性护理用品技术领域,尤其涉及一种含有植物提取物的外阴用护理液及其制备方法。
背景技术
女性随着年龄增加生殖系统逐渐衰老,卵巢功能逐渐减退,雌激素水平下降,阴道黏膜发生干涩、变薄和松弛等退行性变化。同时由于各种原因大小阴唇的颜色也会暗沉变深发黑:(1)遗传因素:不同人种及不同个人的表现型,包括身体所呈现的肤色本质均由体内DNA决定和控制,有些人天生肤色较黑,相应其大小阴唇也呈较深的颜色。(2)性成熟后随时间推移黑色素沉积,这是最主要的原因,组织颜色变深变黑的直接因素就是黑色素沉着,而雌激素会加快黑色素的分泌和沉积,例如怀孕时体内雌激素水平大幅上升,相应的大小阴唇的颜色也会快速加深,另外由于工作生活压力过大,内分泌失调雌激素水平失控,也会加速黑色素的沉积。正常情况下随着体内雌激素的周期性循环,黑色素在大小阴唇上逐渐沉积,故岁月流逝女性局部组织颜色慢慢暗沉深黑。(3)妇科疾病的刺激也会导致阴唇颜色发黑,如果再使用一些有刺激性的药物或产品会进一步加重黑色素在阴道组织部位沉着。
目前,市场上的妇科阴道护理产品众多,但大多侧重消炎、抑菌功效,对阴道几乎没有滋养作用,特别是针对活化、粉嫩外阴的产品基本没有。
发明内容
本发明是为了解决上述不足,提供了一种含有植物提取物的外阴用护理液及其制备方法,能够有效粉嫩外阴、活化阴道组织细胞、恢复并保持阴道组织的自然弹性且高效、延缓女性阴道细胞衰老并且温和安全。
本发明的上述目的通过以下的技术方案来实现:一种含有植物提取物的外阴用护理液,由以下重量百分比的原料制成:多糖0.5%-10%、蛋白质0.5%-3%、植物提取物10%-20%、抗氧化剂1%-5%、保湿剂5%-15%、增稠剂0.02%-0.4%、抗菌剂0.01%-0.1%、防腐剂0.05%-0.5%,余量为纯化水。
进一步的:
所述多糖为羟丙基环糊精。羟丙基环糊精的粘合力使组织黏膜产生明确的表面机械变形,形成的弹性薄膜能够产生平滑作用,可以把一些卷曲的角质层细胞边缘粘住,瞬时缓解粗糙鳞片的组织纹理,同时可以防止水分流失,软化角质层,间接增加皮肤水合作用。
所述蛋白质选自胶原蛋白、水解胶原蛋白、水解明胶中的一种或几种。
所述植物提取物按包含金银花提取物0.1%-0.5%、金缕梅提取物4%-8%、洋甘菊提取物4%-8%、地黄提取物0.5%-3%、芦荟提取液0.5%-3%和金盏花提取物1%-5%,以上百分比均基于总原料的重量百分比。
金银花提取物主要成份为绿原酸,含挥发油、香豆素、黄酮 甙 、内酯及鞣质和香味在单位时间内能对有害物质和异臭味发挥最大的降解作用。对金黄色葡萄球菌、大肠杆菌、绿脓杆菌、真菌等具有很强的抑菌效果,且能保护皮肤。
洋甘菊提取物,具有抗老化修复损伤细胞,促进细胞增殖和组织再生,强化组织增强组织弹性;能刺激白细胞、增强免疫能力;温和不刺激润泽肌肤,同时能滋养体表毛发;另一重要作用是舒缓,缓解发炎和疼痛症状,具有组织净化和保养功效。
芦荟提取物含有葡萄酸、甘糖露、维生素、矿物质、芦蔡甙、异芦荟甙、芦荟大黄素等活性成分,发挥营养保湿、淡化黑色素和防止黑色素产生的作用,激活细胞活力,延缓皮肤衰老,具有使皮肤收敛、柔软化、保湿、抑菌消炎、漂白的性能。
金盏花提取物,富含多种维生素,尤其是维生素A和维生素C,可预防色素沉淀,粉嫩阴部组织提升色泽,减缓衰老避免组织松弛失去弹性;所含的糖类物质具有度刺激引起的黑色素沉积;具有抗菌消炎的作用。刺激免疫,增强免疫系统作用;能调节荷尔蒙,平衡雌激素。
金缕梅提取物,具有舒缓、收敛、抗菌和杀菌的效果。
地黄提取物含有甘露醇、蔗糖、氨基酸、环烯醚萜组分等,具有改善血液循环、改善皮肤暗哑、滋阴补血的功效。
所述抗氧化剂为维生素C和/或其衍生物。
所述保湿剂选自甘油、丙二醇、丁二醇、戊二醇中的一种或多种。
所述增稠剂选自黄原胶、脱氢黄原胶、甲基纤维素、羧甲基纤维素、乙基纤维素、羟乙基纤维素、羟丙基甲基纤维素、羟丙基纤维素中的一种或多种。
所述抗菌剂为醋酸氯己定和/或聚六亚甲基双胍。
所述防腐剂选自杰马BP、辛酰羟肟酸、苯氧乙醇和乙基己基甘油中的一种或多种。
该含有植物提取物的外阴用护理液的制备方法为:
包括如下步骤:
1)在反应罐中加入适量纯化水;
2)常温下将保湿剂、增稠剂混合搅拌均匀,加入反应罐中,50-80℃条件下搅拌至溶解;
2)将蛋白质用适量纯化水在50-80℃水浴中搅拌至溶解,加入反应罐中,搅拌均匀;
3)将反应罐中液体将至室温,然后依次加入植物提取物、多糖、抗氧化剂、抗菌剂、防腐剂,搅拌至完全溶解,混合均匀,静置消泡后即得妇科外阴用护理液。
本发明所涉及的一种含有植物提取物的外阴用护理液及其制备方法,具有滋养、活化阴道组织细胞,使外阴粉嫩的作用,并且恢复和保持阴道组织的自然弹性,延缓女性阴道细胞衰老,而且性质温和安全无刺激,健康环保,无需清洗,携带方便,制作工艺简单,同时具有很好的消炎、抑菌功能。
具体实施方式
下面结合实施例对本发明进一步详述。
实施例1
一种含有植物提取物的外阴用护理液及其制备方法,由以下重量百分比的原料制成:羟丙基环糊精8%、胶原蛋白1%、植物提取物14%(金银花提取物0.5%、金缕梅提取物4%、洋甘菊提取物4%、地黄提取物3%、芦荟提取液0.5%、金盏花提取物2%)、3-O-乙基抗坏血酸 1%、保湿剂15%(甘油10%、丙二醇5%)、乙基纤维素0.1%、醋酸氯己定0.1%、苯氧乙醇 0.1%,余量为纯化水。
本实施例的含有植物提取物的外阴用护理液的制备方法如下:在反应罐中加入适量纯化水;常温下将甘油、丙二醇、乙基纤维素混合搅拌均匀,加入反应罐中,50℃条件下搅拌至溶解;将胶原蛋白用适量纯化水在50℃水浴中搅拌至溶解,加入反应罐中,搅拌均匀;将反应罐中液体将至室温,然后依次加入植物提取物、多糖、抗氧化剂、抗菌剂、防腐剂,搅拌至完全溶解,混合均匀,静置消泡后即得所需妇科外阴用护理液。
本实施例的由上述含有植物提取物的外阴用护理液制备得到的护理膜,通过以下方法制得:将制备的妇科外阴用护理液灌装至瓶或袋,然后将无菌无纺布浸没于瓶或袋内的妇科外阴用护理液中,最后将瓶或袋密封。
所述无菌无纺布也可用天然棉面膜材质、蚕丝面膜材质、天丝面膜材质、水凝胶面膜材质或生物纤维面膜材质替代。
实施例2
一种含有植物提取物的外阴用护理液,由以下重量百分比的原料制成:羟丙基环糊精1%、水解胶原蛋白3%、植物提取物17%(金银花提取物0.5%、金缕梅提取物6%、洋甘菊提取物3%、地黄提取物3.5%、芦荟提取液1%、金盏花提取物3%)、维生素C 3%、保湿剂9%(甘油4%、戊二醇5%)、羟乙基纤维素0.3%、聚六亚甲基双胍0.04%、杰马BP 0.04%,余量为纯化水。
本实施例的含有植物提取物的外阴用护理液的制备方法如下:在反应罐中加入适量纯化水;常温下将甘油、戊二醇、羟乙基纤维素混合搅拌均匀,加入反应罐中,80℃条件下搅拌至溶解;将水解胶原蛋白用适量纯化水在80℃水浴中搅拌至溶解,加入反应罐中,搅拌均匀;将反应罐中液体将至室温,然后依次加入植物提取物、多糖、抗氧化剂、抗菌剂、防腐剂,搅拌至完全溶解,混合均匀,静置消泡后即得所需妇科外阴用护理液。
以上所述仅为本发明的实施例,并非因此限制本发明的专利范围,凡是利用本发明说明书及实施例内容所作的等效结构或等效流程变换,或直接或间接运用在其他相关的技术领域,均同理包括在本发明的专利保护范围内。
Claims (10)
1.一种含有植物提取物的外阴用护理液,其特征在于,由以下重量百分比的原料制成:多糖0.5%-10%、蛋白质0.5%-3%、植物提取物10%-20%、抗氧化剂1%-5%、保湿剂5%-15%、增稠剂0.02%-0.4%、抗菌剂0.01%-0.1%、防腐剂0.05%-0.5%,余量为纯化水。
2.根据权利要求1所述的一种含有植物提取物的外阴用护理液,其特征在于,所述多糖为羟丙基环糊精。
3.根据权利要求1所述的一种含有植物提取物的外阴用护理液,其特征在于,所述蛋白质选自胶原蛋白、水解胶原蛋白、水解明胶中的一种或几种。
4.根据权利要求1所述的一种含有植物提取物的外阴用护理液,其特征在于,所述植物提取物按包含金银花提取物0.1%-0.5%、金缕梅提取物4%-8%、洋甘菊提取物4%-8%、地黄提取物0.5%-3%、芦荟提取液0.5%-3%和金盏花提取物1%-5%,以上百分比均基于总原料的重量百分比。
5.根据权利要求1所述的一种含有植物提取物的外阴用护理液,其特征在于,所述抗氧化剂为维生素C和/或其衍生物。
6.根据权利要求1所述的一种含有植物提取物的外阴用护理液,其特征在于,所述保湿剂选自甘油、丙二醇、丁二醇、戊二醇中的一种或多种。
7.根据权利要求1所述的一种含有植物提取物的外阴用护理液,其特征在于,所述增稠剂选自黄原胶、脱氢黄原胶、甲基纤维素、羧甲基纤维素、乙基纤维素、羟乙基纤维素、羟丙基甲基纤维素、羟丙基纤维素中的一种或多种。
8.根据权利要求1所述的含有植物提取物的外阴用护理液,其特征在于,所述抗菌剂为醋酸氯己定和/或聚六亚甲基双胍。
9.根据权利要求1所述的含有植物提取物的外阴用护理液,其特征在于,所述防腐剂选自杰马BP、辛酰羟肟酸、苯氧乙醇和乙基己基甘油中的一种或多种。
10.根据权利要求1所述的一种含有植物提取物的外阴用护理液的制备方法,其特征在于,包括如下步骤:
1)在反应罐中加入适量纯化水;
2)常温下将保湿剂、增稠剂混合搅拌均匀,加入反应罐中,50-80℃条件下搅拌至溶解;
2)将蛋白质用适量纯化水在50-80℃水浴中搅拌至溶解,加入反应罐中,搅拌均匀;
3)将反应罐中液体将至室温,然后依次加入植物提取物、多糖、抗氧化剂、抗菌剂、防腐剂,搅拌至完全溶解,混合均匀,静置消泡后即得妇科外阴用护理液。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810967951.4A CN108743780A (zh) | 2018-08-23 | 2018-08-23 | 一种含有植物提取物的外阴用护理液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810967951.4A CN108743780A (zh) | 2018-08-23 | 2018-08-23 | 一种含有植物提取物的外阴用护理液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108743780A true CN108743780A (zh) | 2018-11-06 |
Family
ID=63966975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810967951.4A Pending CN108743780A (zh) | 2018-08-23 | 2018-08-23 | 一种含有植物提取物的外阴用护理液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108743780A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111905037A (zh) * | 2020-08-13 | 2020-11-10 | 广州睿森生物科技有限公司 | 一种护理组合物、护理产品及其制备方法 |
CN116370380A (zh) * | 2023-04-24 | 2023-07-04 | 杭州孺子牛健康管理有限公司 | 一种抗衰老组合植物精华药物 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1533762A (zh) * | 2003-03-31 | 2004-10-06 | 吴天祥 | 仿生皮肤及阴道护理液 |
CN101513525A (zh) * | 2008-02-19 | 2009-08-26 | 白大成 | 胶原蛋白及其药物组合物在妇科方面的应用 |
CN104207957A (zh) * | 2014-09-17 | 2014-12-17 | 深圳港品一家实业有限公司 | 一种具有缩阴美白作用的蚕丝蛋白护理液及其制备方法 |
CN105581926A (zh) * | 2016-02-25 | 2016-05-18 | 刘忠波 | 女性私处护理液及其制备方法 |
CN107432890A (zh) * | 2017-08-16 | 2017-12-05 | 青岛大师兄生物科技有限公司 | pH敏感型女性护理产品及其制备方法 |
-
2018
- 2018-08-23 CN CN201810967951.4A patent/CN108743780A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1533762A (zh) * | 2003-03-31 | 2004-10-06 | 吴天祥 | 仿生皮肤及阴道护理液 |
CN101513525A (zh) * | 2008-02-19 | 2009-08-26 | 白大成 | 胶原蛋白及其药物组合物在妇科方面的应用 |
CN104207957A (zh) * | 2014-09-17 | 2014-12-17 | 深圳港品一家实业有限公司 | 一种具有缩阴美白作用的蚕丝蛋白护理液及其制备方法 |
CN105581926A (zh) * | 2016-02-25 | 2016-05-18 | 刘忠波 | 女性私处护理液及其制备方法 |
CN107432890A (zh) * | 2017-08-16 | 2017-12-05 | 青岛大师兄生物科技有限公司 | pH敏感型女性护理产品及其制备方法 |
Non-Patent Citations (1)
Title |
---|
唯美心语: "英国众多女性的选择!戴安娜王妃推荐私处护理液,抑菌、止痒解决你的私处小尴尬!", 《唯美心语》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111905037A (zh) * | 2020-08-13 | 2020-11-10 | 广州睿森生物科技有限公司 | 一种护理组合物、护理产品及其制备方法 |
CN116370380A (zh) * | 2023-04-24 | 2023-07-04 | 杭州孺子牛健康管理有限公司 | 一种抗衰老组合植物精华药物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103565728B (zh) | 一种黑果枸杞美白保湿柔肤水及其制备方法 | |
CN108143702A (zh) | 一种高效美白补水面膜液、面膜及其制备方法 | |
CN105769698A (zh) | 一种不含防腐剂的化妆品组合物及其应用 | |
CN107714504A (zh) | 一种同人源胶原蛋白组合物及其在化妆品中应用 | |
CN104825382A (zh) | 生物科技美白护肤品 | |
CN105168054A (zh) | 一种补水增白祛皱面膜及其制备方法 | |
CN110464658B (zh) | 一种多效眼部冻干膜及蒸汽眼罩 | |
CN105796474A (zh) | 一种固体多功能面膜组合物及制备面膜的方法 | |
CN102579315A (zh) | 一种应用在化妆品中的植物组合物及其应用方法 | |
CN101961298B (zh) | 保湿组合物 | |
CN108261376A (zh) | 一种三维保湿因子 | |
CN107693381A (zh) | 一种含有柔性纳米脂质体的巴布贴面膜 | |
CN103385820A (zh) | 一种修护眼霜 | |
CN103211742B (zh) | 一种含美洲接骨木提取物、三色堇花提取物和水解珍珠的瞬透生肌水组合物的制备方法 | |
CN112656709A (zh) | 皮肤护理组合物及其应用 | |
CN108743780A (zh) | 一种含有植物提取物的外阴用护理液及其制备方法 | |
CN108524354A (zh) | 护肤组合物、护肤面膜及其制备方法 | |
CN109464364A (zh) | 一种含有氧化石墨烯的祛斑护肤制剂及制备方法 | |
CN108309894A (zh) | 修复妊娠纹的组合物、修复霜、制备方法及修复系统 | |
CN106727251A (zh) | 一种天然蜂毒凝胶霜及其制备工艺 | |
CN103735455B (zh) | 一种紫菜水煮藻泥面膜及其制备方法 | |
CN110721102A (zh) | 一种具有保湿抗皱抗氧化作用的眼膜 | |
JPS61158912A (ja) | 皮膚改善用組成物 | |
CN110496069A (zh) | 一种小分子聚肽原液及其制备方法 | |
CN105640836B (zh) | 一种含有荷花活性成分的护肤水及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190220 Address after: 310000 Yuhang District, Hangzhou City, Zhejiang Province, No. 2959 Yuhangtang Road, Cangqian Street, 4 buildings and 1 storey Applicant after: Zhejiang Inotai Medical Devices Co., Ltd. Address before: 310000 Room 458, Building 3, No. 1, Luting Road, Cangqian Street, Yuhang District, Hangzhou City, Zhejiang Province Applicant before: HANGZHOU YOUNG CELL BIOTECHNOLOGY CO., LTD. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181106 |